2018 American Association for Cancer Research (AACR) Annual Meeting - X4 Pharmaceuticals

2018 American Association for Cancer Research (AACR) Annual Meeting

2018 American Association for Cancer Research (AACR) Annual Meeting

April 2018

X4P-001, an Orally Bioavailable CXCR4 Antagonist, Enhances Immune Cell Infiltration and Activation in the Tumor Microenvironment of Melanoma
CXCR4 Inhibition Modulates Tumor Microenvironment and Robustly Inhibits Growth of B16-OVA Melanoma

© Copyright 2024 X4 Pharmaceuticals. All Rights Reserved. Terms of Use | Privacy | Compliance and Ethics